The trademark application was filed by A:head bio AG, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on February 11, 2020, and it was registered by office on May 21, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on July 2, 2020.
Goods And Services
The mark was filed in class 1 with following description of goods:
Biological preparations for use in industry and science
Biological preparations for use in the research and development of pharmaceutical preparations or medical products
Biological preparations for use as a model of brain cells or brains
Cellular brain models for use in industry and science
Neural cell preparations
Stem cell preparations for use in industry and science
Stem cells of human or animal origin for use in industry and science.
The mark was filed in class 5 with following description of goods:
Pharmaceuticals, medical preparations in the field of central nervous system diseases or disorders
Pharmaceuticals, medical preparations for the treatment of neurological disorders or diseases
Pharmaceuticals, medical preparations for the treatment of genetic epileptic encephalopathy or Dravet syndrome.
The mark was filed in class 42 with following description of goods:
Medical and pharmaceutical research and development in the field of central nervous system diseases or disorders
Medical and pharmaceutical research and development for the treatment of neurological disorders or diseases
Medical and pharmaceutical research and development for the treatment of genetic epileptic encephalopathy or Dravet syndrome
Scientific research and development services in the field of central nervous system diseases or disorders
Scientific research and development services for developing products for use in the treatment of neurological disorders or diseases
Scientific research and development services for developing products for use in the treatment of genetic epileptic encephalopathy or Dravet syndrome
Providing scientific research information and results
Industrial research in the field of central nervous system diseases or disorders
Industrial research for developing products for use in the treatment of neurological disorders or diseases
Industrial research for developing products for use in the treatment of genetic epileptic encephalopathy or Dravet syndrome
Professional consultancy services in the fields of pharmaceutical research and development
Contract research services related to products in the field of pharmacy and biotechnology.